Presented by Joel Brill, MD at the SAGES 2014 Meeting; Symposium: Ethics of Innovation
disclosures–19 sec
critical milestones in development–1:28
how does a new item or service fit into the U.S. healthcare system?–2:19
reimbursement trends–2:50
fee-for-service vs fee-for-value–
Keyword(s): administrators, aggregate data, BCBS, beneficiary, budget neutrality, bundled payment method, bundled services, CE, centers of excellence, challenges, Cigna, claim, clinical outcome, clinical outcomes, clinical trials, CMS, coding, collaboration, colorectal cx screening, commercial payors, commercialization, comparative clinical studies, comparative effectiveness studies, consolidation, cost effective care, coverage, coverage strategy, CSP, data collection, decision-making, device manufactures, EarlyBirdAlert, EndoChoice, equity, ethics, evidence-based, FAIR Health Inc, FDA, fee-for-service, fee-for-value, financial risk, Gastroenterology, gold standard, government, GPO, health outcomes, healthcare reform, Humana, innovation, inpt setting, insurers, investigational services, lab tests, lap surgery, legal document, liquidity event, local coverage, long-term benefits, manufacturer, marketplace, Medi-Cal, medical necessity, medical practitioner, Medicare, national coverage, national healthcare, networks, new technologies, non-surgical care, NPI, out of network database, outpt setting, payment, payment models, payment rates, payors, peer reviewed, personal shares, pharmaceutical industry, pharmacy, population, private sector, profits, providers, quality, regulatory approval, reimbursement, safety, scientific evidence, stakeholders, standards of medical practice, supplier, symptom improvement, terms & conditions, third-party payors, trials, U.S., UHC, United Health Group, workup